Recent Notable Insider Trades: KalVista Pharmaceuticals, Nuveen Churchill Direct Lending, and FB Financial
Although U.S. stocks closed higher on Monday, there were a few notable insider trades that caught the attention of investors. Insider trades can provide valuable insights into the company’s prospects and can serve as a potential opportunity for investors. Here are some recent notable insider trades:
KalVista Pharmaceuticals:
– The Trade: KalVista Pharmaceuticals, Inc. 10% owner Nimish Shah acquired a total of 91,804 shares at an average price of $14.05, costing around $1.29 million.
– What’s Happening: Last month, KalVista Pharma announced the publication of its first oral factor XIIa data in Frontiers in Pharmacology.
– What KalVista Pharmaceuticals Does: KalVista Pharmaceuticals Inc. is a pharmaceutical company that focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.
Nuveen Churchill Direct Lending:
– The Trade: Nuveen Churchill Direct Lending Corp. 10% owner America of Association Annuity Insurance Teachers acquired a total of 1,662,050 shares at an average price of $18.05, costing around $30 million.
– What’s Happening: The company recently priced its IPO at $18.05 per share.
– What Nuveen Churchill Direct Lending Does: Nuveen Churchill Direct Lending Corp is a specialty finance company focused primarily on investing in senior secured loans to private equity-owned U.S. middle market companies.
FB Financial:
– The Trade: FB Financial Corporation Director Raja Jubran bought a total of 14,808 shares at an average price of $26.97, costing around $399,416.
– What’s Happening: Hovde Group analyst Brett Rabatin recently downgraded FB Financial from Outperform to Market Perform and announced a $40 price target.
– What FB Financial Does: FB Financial Corp is a bank holding company that provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia.
It’s important to note that insider purchases should not be the sole indicator for making investment or trading decisions. However, they can provide conviction to a buying decision. Investors should conduct thorough research and consider various factors before making any investment decisions.
For more information on insider trades and other market news, you can visit Benzinga’s insider transactions platform. Additionally, don’t forget to check out Benzinga’s premarket coverage for the latest updates on the market.
Disclaimer: This article is for informational purposes only and should not be considered as investment advice. All rights reserved.
